---
accession : E-GEOD-35230
platform  : A-AFFY-44
pathway   : MAPK
cells     : A375 Melanoma cell line
treatment : 10 nM GSK1120212
effect    : inhibiting
hours     : 24

control   :
    - GSM864257 1
    - GSM864258 1
    - GSM864294 1
perturbed :
    - GSM864263 1
    - GSM864264 1
    - GSM864265 1

---
accession : E-GEOD-35230
platform  : A-AFFY-44
pathway   : MAPK
cells     : A375 Melanoma cell line
treatment : 30 nM GSK1120212
effect    : inhibiting
hours     : 24

control   :
    - GSM864257 1
    - GSM864258 1
    - GSM864294 1
perturbed :
    - GSM864266 1
    - GSM864267 1

---
accession : E-GEOD-35230
platform  : A-AFFY-44
pathway   : MAPK
cells     : A375 Melanoma cell line
treatment : 0.1 uM GSK2118436
effect    : inhibiting
hours     : 24

control   :
    - GSM864257 1
    - GSM864258 1
    - GSM864294 1
perturbed :
    - GSM864259 1
    - GSM864260 1

---
accession : E-GEOD-35230
platform  : A-AFFY-44
pathway   : MAPK
cells     : A375 Melanoma cell line
treatment : 1 uM GSK2118436
effect    : inhibiting
hours     : 24

control   :
    - GSM864257 1
    - GSM864258 1
    - GSM864294 1
perturbed :
    - GSM864261 1
    - GSM864262 1

---
accession : E-GEOD-35230
platform  : A-AFFY-44
pathway   : MAPK
cells     : A375 Melanoma cell line
treatment : 10 nM GSK1120212 + 0.1 uM GSK2118436
effect    : inhibiting
hours     : 24

control   :
    - GSM864257 1
    - GSM864258 1
    - GSM864294 1
perturbed :
    - GSM864268 1
    - GSM864269 1
    - GSM864270 1

---
accession : E-GEOD-35230
platform  : A-AFFY-44
pathway   : MAPK
cells     : A375 Melanoma cell line
treatment : 10 nM GSK1120212 + 1 uM GSK2118436
effect    : inhibiting
hours     : 24

control   :
    - GSM864257 1
    - GSM864258 1
    - GSM864294 1
perturbed :
    - GSM864271 1
    - GSM864272 1
    - GSM864273 1
...
